Back
ESC Premium Access

State of the Art: P2Y12 inhibitors in acute coronary syndromes

Session: P2Y12 inhibitors in acute coronary syndromes
Topic: Thrombosis and platelets
Speaker: Professor D. Bhatt (New York, US)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York (United States of America)
52 presentations
14 followers

4 more presentations in this session

Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction in relation to renal function: 1-year SWEDEHEART registry data.

Speaker: Doctor R. Edfors (Stockholm, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry.

Speaker: Doctor P. Riedmaier (Ludwigshafen, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction : a systematic review and meta-analysis

Speaker: Doctor A. Bellemain-Appaix (Antibes, FR)

Access
Abstract
Like
Thumbnail

Future perspectives for antithrombotic strategy after acute coronary syndromes

Speaker: Professor R. Storey (Sheffield, GB)

Access
Slides
Video
Like
Thumbnail

Access the full session

P2Y12 inhibitors in acute coronary syndromes

Speakers: Professor D. Bhatt, Doctor R. Edfors, Doctor P. Riedmaier, Doctor A. Bellemain-Appaix, Professor R. Storey
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources